TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
  1. Omesh K. Bharti
  2. Service delivery
  3. Sunday, 08 May 2011
Dear Moderator, I am perturbed to know that people of Bangladesh have to pay Tk 40.25 to get obsolete Nerve Tissue Vaccine (NTV), recommended not to be used by WHO, but they are getting Pentavalent Free ! Banglaseh spends approximately Tk 1 crore ( 10 Million )every year on nerve tissue vaccine. I appeal to donor agencies to help Bangladesh procure and produce tissue culture antirabies vaccine so that many people (about 1500) could be saved from the jaws of death and a lot of money of poor patients could be saved. This will also enable them to have life long immunity that can be reactivated on re-exposure through a 4 site intradermal single vial of tissue culture vaccine. If we refer to the paper published in Vaccine, 86.2% receive NTV post exposure in Bangladesh which is a very serious issue and needs attention of policy makers. Regards,
Omesh K. Bharti Accepted Answer
Himachal High Court does not agree to allow intradermal use of Hepatitis-B vaccine Dear Friends, In a recent judgement, the Himachal High Court does not agree to allow intradermal use of Hepatitis-B vaccine while the government contendes that it can not be done as this is not recommended by any standard books.Though government agreed to give intradermal antirabies vaccine to patients as recommended by WHO. We need to speed up studies on low cost intradermal vaccines as more than 10 can be given through this route including IPV. Generating evidence and then getting it accepted is a long journey that need the attention of the policy makers. Thanks. Dr. Omesh Kumar Bharti, India
  1. more than a month ago
  2. Service delivery
  3. # 1

There are no replies made for this post yet.
Be one of the first to reply to this post!